Professor, Medicine, University of Washington School of Medicine
Gastroenterology
Dr. Brian J. Reid, MD
|
|
Give Review
Brian Reid is an expert in the field of Gastroenterology. He received awards:"Fellow (FACG)". Brian J. Reid, MD has written publications. He has 81 publications published with PubMed. The lastest publication is: 'Research Needs for Understanding the Biology of Overdiagnosis in Cancer Screening.'
Publications
- A Newly Identified Susceptibility Locus near FOXP1 Modifies the Association of Gastroesophageal Reflux with Barrett's Esophagus.
- Research Needs for Understanding the Biology of Overdiagnosis in Cancer Screening.
- Inflammation and Oxidative Stress Markers and Esophageal Adenocarcinoma Incidence in a Barrett's Esophagus Cohort.
- Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma.
- Addressing overdiagnosis and overtreatment in cancer: a prescription for change.
- Intraindividual variability over time in plasma biomarkers of inflammation and effects of long-term storage.
- Risk of Esophageal Adenocarcinoma Decreases with Height, Based on Consortium Analysis and Confirmed by Mendelian Randomization.
- Germline Genetic Contributions to Risk for Esophageal Adenocarcinoma, Barrett's Esophagus, and Gastroesophageal Reflux.
- A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.
- Warburg and Crabtree Effects in Premalignant Barrett's Esophagus Cell Lines with Active Mitochondria.
- Association Between Markers of Obesity and Progression From Barrett's Esophagus to Esophageal Adenocarcinoma.
- The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus.
- Selenium, Selenoenzymes, Oxidative Stress and Risk of Neoplastic Progression from Barrett's Esophagus: Results from Biomarkers and Genetic Variants.
- Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus.
- Early events during neoplastic progression in Barrett''s esophagus.
- New Strategies in Barrett's Esophagus: Integrating clonal evolutionary theory with clinical management.
- Application of biomarkers in cancer risk management: evaluation from stochastic clonal evolutionary and dynamic system optimization points of view.
- A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma.
- Deletion at fragile sites is a common and early event in Barrett's esophagus.
- Decision-makers'' perspectives on the use of bioaccessibility for risk-based regulation of contaminated land.
- Sequential extraction of polycyclic aromatic hydrocarbons using subcritical water.
- Barrett''s oesophagus and oesophageal adenocarcinoma: time for a new synthesis.
- Toxicity of polycyclic aromatic hydrocarbons to the nematode Caenorhabditis elegans.
- Beyond contaminated land assessment: on costs and benefits of bioaccessibility prediction.
- Nonadenomatous dysplasia in barrett esophagus: a clinical, pathologic, and DNA content flow cytometric study.
- Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma.
- Translation of an STR-based biomarker into a clinically compatible SNP-based platform for loss of heterozygosity.
- Compatibility of hydroxypropyl-beta-cyclodextrin with algal toxicity bioassays.
- Assessing biodegradation potential of PAHs in complex multi-contaminant matrices.
- Environmentally friendly assessment of organic compound bioaccessibility using sub-critical water.
- Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study.
- Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression.
- Earthworm assisted bioremediation of organic contaminants.
- The co-application of earthworms (Dendrobaena veneta) and compost to increase hydrocarbon losses from diesel contaminated soils.
- Translational Research Working Group developmental pathway for biospecimen-based assessment modalities.
- Cancer risk assessment and cancer prevention: promises and challenges.
- Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study.
- p16 mutation spectrum in the premalignant condition Barrett's esophagus.
- Leukocyte telomere length predicts cancer risk in Barrett's esophagus.
- Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's es...
- Direct inference of SNP heterozygosity rates and resolution of LOH detection.
- Prediction of microbial accessibility of carbon-14-phenanthrene in soil in the presence of pyrene or benzoapyrene using an aqueous cyclodextrin extraction technique.
- Cyclodextrin enhanced biodegradation of polycyclic aromatic hydrocarbons and phenols in contaminated soil slurries.
- Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH.
- Prediction of PAH biodegradation in field contaminated soils using a cyclodextrin extraction technique.
- Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus.
- NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.
- Cancer as an evolutionary and ecological process.
- Prediction of mono- and polycyclic aromatic hydrocarbon degradation in spiked soils using cyclodextrin extraction.
- Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.
- Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis.
- Reproducible two-dimensional capillary electrophoresis analysis of Barrett's esophagus tissues.
- Chromosomal instability in Barrett's esophagus is related to telomere shortening.
- Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.
- Genetic clonal diversity predicts progression to esophageal adenocarcinoma.
- Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort.
- Neosquamous epithelium does not typically arise from Barrett's epithelium.
- Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation.
- Influence of diesel concentration on the fate of phenanthrene in soil.
- Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett''s oesophagus: a prospective study.
- Natural selection in neoplastic progression of Barrett''s esophagus.
- Towards a more appropriate water based extraction for the assessment of organic contaminant availability.
- Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus.
- Prediction of polycyclic aromatic hydrocarbon biodegradation in contaminated soils using an aqueous hydroxypropyl-beta-cyclodextrin extraction technique.
- Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett''s esophagus.
- Intrinsic and induced isoproturon catabolic activity in dissimilar soils and soils under dissimilar land use.
- The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma.
- Cancer prevention strategies that address the evolutionary dynamics of neoplastic cells: simulating benign cell boosters and selection for chemosensitivity.
- Flow cytometric enrichment for respiratory epithelial cells in sputum.
- Focus on Barrett's esophagus and esophageal adenocarcinoma.
- Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus.
- Influence of hydroxypropyl-beta-cyclodextrin on the extraction and biodegradation of phenanthrene in soil.
- Molecular phenotype of spontaneously arising 4N (G2-tetraploid) intermediates of neoplastic progression in Barrett's esophagus.
- Extended lifespan of Barrett''s esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model.
- Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus.
- Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.
- Induction of PAH-catabolism in mushroom compost and its use in the biodegradation of soil-associated phenanthrene.
- Transcriptional analyses of Barrett's metaplasia and normal upper GI mucosae.
- Single nucleotide polymorphism array analysis of flow-sorted epithelial cells from frozen versus fixed tissues for whole genome analysis of allelic loss in breast cancer.
- Feasibility of RNA and DNA Extraction from Fresh Pipelle and Archival Endometrial Tissues for Use in Gene Expression and SNP Arrays.
Schools
University of Washington
Brigham Womens Hospital
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- Fellow (FACG)
Hospital
-
Seattle Children's Hospital -
University of Washington Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Justin S. Goodman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven M. Shaw, MD |
|
Dr. John J. Brandabur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carol S. Murakami, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig Pepin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cynthia W. Ko, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jasmine K. Zia, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Stacy K. Tong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles M. Janeway, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Hockenbery, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Drew B. Schembre, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sing S. Lam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Inadomi, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Matthew S. Cole, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George B. McDonald Jr., MD |
|
|
Dr. Gregory D. Lutzak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew D. Cole, DPT
This Doctor is OpenDoctor Recommended.
|